# Vitamin D promotes apoptosis and enhances cisplatin sensitivity in bladder cancer cells by inhibiting the Warburg effect through the AKT/mTOR pathway

**Authors:** Jian Zhou, Chaoyang Zhang, Xiao Wang, Ji Xing, Geng Cheng, Hao Chu

PMC · DOI: 10.1186/s12894-025-01994-2 · BMC Urology · 2025-12-15

## TL;DR

Vitamin D improves the effectiveness of cisplatin in bladder cancer by promoting cell death and reducing tumor metabolism through a specific signaling pathway.

## Contribution

This study reveals a novel mechanism by which vitamin D enhances cisplatin sensitivity in bladder cancer via the AKT/mTOR pathway and the Warburg effect.

## Key findings

- Vitamin D and cisplatin together inhibit bladder cancer cell proliferation and promote apoptosis.
- Vitamin D reduces the Warburg effect by downregulating key metabolic proteins like GLUT1 and LDHA.
- The AKT/mTOR pathway is activated by vitamin D, increasing cisplatin sensitivity in bladder cancer cells.

## Abstract

Patients with bladder cancer (BCa) have a poor prognosis and are prone to metastasis. Deficiency of 1,25-dihydroxyvitamin D3 (VD) is associated with increased incidence and decreased survival in various tumors. Herein, we aimed to examine the effect of VD combined with cisplatin (DDP) on the proliferation and apoptosis of BCa cells and elucidate the underlying mechanism.

T24 and 5637 BCa cell lines were treated with different concentrations of DDP and VD to assess the effects of various doses of DDP and VD on BCa cytotoxicity and determine the appropriate combination dose. T24 cells were treated with DDP and VD to assess the effects of the drug combination on cell proliferation, apoptosis, cycling, Warburg effect, and DDP sensitivity. In addition, cells were treated with DDP, VD, pyruvic acid sodium (PAS), or SC79 to determine the effect of VD on the sensitivity of BCa cells to DDP mediated by inhibiting the Warburg effect through AKT/mTOR signaling.

VD and DDP inhibited BCa cell proliferation; promoted apoptosis; downregulated the protein expression of GLUT1, LDHA, HK2, c-Myc, MRP1, and P-gp; and upregulated the expression of p-mTOR protein. VD combined with DDP reversed the effects of PAS on cells and promoted apoptosis by inhibiting the cellular Warburg effect. In addition, VD combined with DDP activated the AKT/mTOR pathway and reversed the effects of SC79 on cell proliferation and the Warburg effect.

VD could promote apoptosis and enhance DDP sensitivity in BCa cells by inhibiting the Warburg effect via the AKT/mTOR pathway.

The online version contains supplementary material available at 10.1186/s12894-025-01994-2.

## Linked entities

- **Genes:** SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513], LDHA (lactate dehydrogenase A) [NCBI Gene 3939], HK2 (hexokinase 2) [NCBI Gene 3099], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609], CD9 (CD9 molecule) [NCBI Gene 928], PGP (phosphoglycolate phosphatase) [NCBI Gene 283871], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475]
- **Chemicals:** 1,25-dihydroxyvitamin D3 (PubChem CID 5280453), cisplatin (PubChem CID 5460033), SC79 (PubChem CID 2810830)
- **Diseases:** bladder cancer (MONDO:0004986)

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}
- **Diseases:** bladder cancer (MESH:D001749)
- **Chemicals:** Vitamin D (MESH:D014807), cisplatin (MESH:D002945)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12822197/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12822197/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12822197/full.md

---
Source: https://tomesphere.com/paper/PMC12822197